India needs to diversify pharma raw material imports, up R & D spends: RBI paper

"The high import dependency and surprisingly low R&D intensity of exports in the Indian pharmaceutical sector call for timely diversification of source countries for importing raw materials so as to mitigate potential supply-side bottlenecks," the paper by Shibanjan Dutta and Dhirendra Gajbhiye said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news